The Alzheimer’s and Dementia Program
Data Reporting Tool (ADP-DRT) is needed in order to: •Collect data
for performance measures used in the justification of the budget to
Congress and by program, state and national decision makers.
•Effectively manage the ACL’s Alzheimer’s Disease Program at the
federal, state and local levels. •Advocate at the federal and state
levels for more effective and efficient supports and services for
persons with Alzheimer’s disease and their caregivers. The ADP-DRT
collects information about the delivery of supports and services by
the Administration for Community Living (ACL) Alzheimer’s Disease
Program grantees, including basic demographic information about
service recipients and spending on direct services and
administrative expenses. The Older American’s Act requires ACL to
evaluate “demonstration projects that support the objectives of
this Act, including activities to bring effective demonstration
projects to scale with a prioritization of projects that address
the needs of under served populations, and promote partnerships
among aging services, community-based organizations, and Medicare
and Medicaid providers, plans, and health (including public health)
systems. (Section 201 (42 U.S.C. 3011) Sec. 127. Research and
Evaluation). To fulfill the evaluation requirements and allow for
optimal federal and state-level management of the program, specific
information must be collected from grantees, including the
following: A. The number of persons with Alzheimer’s disease or
related dementia or at high risk of dementia and/or their
caregivers served by the program and their respective demographic
characteristics. B. The number of professionals trained in dementia
education, care and best practices. C. Information about grant
funds spent on direct services, program administration costs and
general organizational administrative costs. D. The provision of
direct services to persons with Alzheimer’s disease or related
dementia or at high risk of dementia and/or their caregivers.
Information from the ADP-DRT will be provided to: federal and state
legislators; state agencies on aging; national, state and local
organizations with an interest in Alzheimer’s disease and related
dementia and long-term care issues; current and future ACL
Alzheimer’s Disease Program grantees; and private citizens who
request it. Information will be posted on ACL’s National
Alzheimer’s and Dementia Resource Center (NADRC) website.
There is a program change
increase of 1346 annual burden hours. The annual reporting burden
hour estimates have increased from 983 to 2,329. The following
reasons account for the change in burden hour estimates: • The new
estimates are for 90 grants, rather than the 38 grants from the
previous ADP-DRT approval, a 136% increase in the number of grants.
• Although, for data set approved in 2016, it was anticipated that
grantee respondents would spend 25.88 hours reporting annually, the
actual number of hours spent (local partners and grantee combined),
as reported by the current ADP grantees consulted, was 19.92 hours
annually per grant. The following reasons account for the change in
burden cost estimates: • The new estimates are for 90 grants,
rather than the 38 grants from the previous ADP-DRT approval. This
also include data collection from 180 local partners, rather than
76 local partners from the previous ADP-DRT approval • The pay
grades and pay rates for local partner and grantee staff increased
between 2016 and 2020. • The annualized cost to the federal
government increased due to increased contractor costs to analyze
the data of the increased in the number of grantees and a pay grade
increase for the federal project officer.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.